Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?

The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...]

Bibliographic Details
Main Authors: Marco Caminati, Gabriella Guarnieri, Gianenrico Senna
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Vaccines
Subjects:
n/a
Online Access:https://www.mdpi.com/2076-393X/9/1/38